Xa inhibitor edoxaban ameliorates hepatic ischemia-reperfusion injury via PAR-2-ERK 1/2 pathway.
Maeda K, Kuriyama N, Noguchi D, Ito T, Gyoten K, Hayasaki A, Fujii T, Iizawa Y, Murata Y, Tanemura A, Kishiwada M, Mizuno S.
Maeda K, et al. Among authors: ito t.
PLoS One. 2024 May 15;19(5):e0292628. doi: 10.1371/journal.pone.0292628. eCollection 2024.
PLoS One. 2024.
PMID: 38748746
Free article.